Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu (Q39679811)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 13 July 2010

Language	Label	Description	Also known as
English	Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu	scientific article published on 13 July 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

0 references

0 references

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

author name string

Yanique Rattigan

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jing-Mei Hsu

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Pravin J Mishra

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

John Glod

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Debabrata Banerjee

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

13 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Experimental Cell Research

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

316

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

3417-3424

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

The tumor microenvironment and metastatic disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Molecular responses to hypoxia in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Regulation of angiogenesis by hypoxia: role of the HIF system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Molecular Mechanisms of Tumor Invasion and Metastasis: An Integrated View

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Hypoxia, gene expression, and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Microenvironment-induced cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Hypoxia-driven selection of the metastatic phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Differential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Putting tumours in context

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

The influence of the microenvironment on the malignant phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

The human tumor microenvironment: invasive (needle) measurement of oxygen and interstitial fluid pressure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Tumor microenvironmental physiology and its implications for radiation oncology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

The hypoxic tumour microenvironment and metastatic progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Tumor hypoxia and cancer progression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Drug resistance and the solid tumor microenvironment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Interleukin-6: from basic science to medicine--40 years in immunology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

IL-6 involvement in epithelial cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Optimizing therapeutic strategies to inhibit circulating soluble target molecules with monoclonal antibodies: example of the soluble IL-6 receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Cytokine-binding proteins: stimulating antagonists

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2010.07.002

7 January 2021

Identifiers

10.1016/J.YEXCR.2010.07.002

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39679811&oldid=1855511572"